2011年 5月 6日
The US Food and Drug Administration has published final guidance targeting over-the-counter drug products packaged with syringes, droppers and other dispensing devices.
Dispensing devices can minimize the risk of accidental overdoses, according to the guidance; the agency issued the guidance to address concerns over unclear or inconsistently marked dosage delivery devices.
The guidance’s specific recommendations for manufacturers include: